KHK2455

· Kyowa Kirin, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for KHK2455, covering 2024-04-25 to 2024-04-25. Get the full timeline:

Most recent: Clinical Trial Update: KHK2455 Alone and in Combination With Mogamulizumab in Subjects With Locally Advanced or Metastatic Solid Tumors [Phase 1]

See pricing